Home・Stock List・Quanterix Corp

Quanterix Corp

Closed

SectorHealthcare

4.01 4.97

Buy Sell

Overview

Share price change

24h

Current

Min

3.82

Max

4.03

Key metrics
By Trading Economics
Income	5.6M -18M
Sales	-7.4M 36M
EPS	0.16
Profit margin	-48.17
Employees	450
EBITDA	5.5M -11M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+4.44% upside

Dividends
By Acuity
Next Earnings	10 Aug 2026

Market Stats
By TradingEconomics
Market Cap	16M 175M
Previous open	-0.96
Previous close	4.01

News Sentiment

By Acuity

50%

168 / 340 Healthcare

Quanterix Corp Chart

Past performance is not a reliable indicator of future results.

Related News

5 Aug 2026, 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

3 Aug 2026, 19:26 UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

31 Jul 2026, 19:46 UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

30 Jul 2026, 19:59 UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

29 Jul 2026, 19:43 UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

28 Jul 2026, 20:06 UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

27 Jul 2026, 16:06 UTC

Quanterix Corp shares are higher today, following a strong opening. No specific news was identified to explain the price movement.

24 Jul 2026, 19:53 UTC

Quanterix Corp shares are lower today, continuing a decline since Thursday amid broader market uncertainty from oil volatility and new U.S. tariffs.

22 Jul 2026, 19:36 UTC

Quanterix Corp shares are lower in Wednesday's session, continuing a decline since Tuesday's close amid rising crude oil prices and market concerns.

21 Jul 2026, 21:26 UTC

Quanterix Corp shares are higher in after-market hours, reflecting positive trading momentum. Broader market strength may be influencing sentiment following the close.

20 Jul 2026, 19:46 UTC

Quanterix Corp shares are higher today amid positive market sentiment and a notable rise in the Hang Seng 50 Index, despite no specific company news.

Peer Comparison

Price change

Quanterix Corp Forecast

Price Target

By TipRanks

4.44% upside

12 Months Forecast

Average 4 USD 4.44%

High 4 USD

Low 4 USD

Based on 1 Wall Street analysts offering 12 month price targets forQuanterix Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to Quanterix Corp - Dist in the past 3 months.

Sentiment

By Acuity

168 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.